ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 745451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 745451; 2) Community: the network communities that were significantly associated with the response to NSC 745451; 3) Molecule: the relationships between components within communities and NSC 745451; 4) MDR: the compounds that were significantly associated with the NSC 745451.

NSC Compound Enrichment Correlation
NSC 756169 GSK317314A 0.0467178916101838 0.49470275
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0467178916101838 0.2718837
NSC 92504 Null 0.0467178916101838 0.51040662
NSC 100071 component of Halotex 0.0467178916101842 0.43158183
NSC 109451 Null 0.0467178916101842 -0.064060875
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0467178916101842 0.37524291
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0467178916101842 0.35591849
NSC 176503 Fastigilin B 0.0467178916101842 0.38947423
NSC 24030 p-Phenylenediamine (8CI), N-butyl-N'-phenyl- 0.0467178916101842 0.38511308
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0467178916101842 0.19728311
Total:139  Current:121    [First] [Prev] [Next] [Last]